Evidence map›Paper›PMID 37734924›Full record

ArticleThe FEBS journal2023

Functional and structural properties of pyridoxal reductase (PdxI) from Escherichia coli: a pivotal enzyme in the vitamin B6 salvage pathway.

Angela Tramonti, Akua K Donkor, Alessia Parroni, Faik N Musayev, Anna Barile, Mohini S Ghatge, Claudio Graziani, Mona Alkhairi, Mohammed AlAwadh, Martino Luigi di Salvo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. A new branch of mammalian vitamin BThe FEBS journal · 2026
    Article
  2. Review
  3. Vitamin BCommunications biology · 2025
    Article
  4. Identification of YigL as a PLP/PNP phosphatase inApplied and environmental microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Angela TramontiIstituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Roma, Italy.ORCID 0000-0002-5625-1170
Akua K DonkorDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Alessia ParroniIstituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Roma, Italy.
Faik N MusayevDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Anna BarileIstituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Roma, Italy.
Mohini S GhatgeDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Claudio GrazianiIstituto Pasteur Italia-Fondazione Cenci Bolognetti and Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy.
Mona AlkhairiDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Mohammed AlAwadhDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.
Martino Luigi di SalvoIstituto Pasteur Italia-Fondazione Cenci Bolognetti and Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy.
Martin K SafoDepartment of Medicinal Chemistry, School of Pharmacy, Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0002-9536-1743
Roberto ContestabileIstituto Pasteur Italia-Fondazione Cenci Bolognetti and Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy.ORCID 0000-0002-5235-9993
Virginia Commonwealth University · USIstituto Pasteur · ITInstitute of Molecular Biology and Pathology · ITHealth First · US

Funding

Pyridoxal 5'-phosphate homeostasis in Escherichia coliR01GM129793 · NIGMS · UNIVERSITY OF FLORIDA · PI DE CRECY-LAGARD, VALERIE A · 2019 to 2022
$1.2M
X-ray Crystallographic Data Collection SystemS10OD021756 · OD · VIRGINIA COMMONWEALTH UNIVERSITY · PI SAFO, MARTIN K · 2017 to 2017
$600k
NIGMS NIH HHS R01 GM129793NIH HHS GM129793NIH HHS S10 OD021756
6 · The paper itself

Abstract

Pyridoxine 4-dehydrogenase (PdxI), a NADPH-dependent pyridoxal reductase, is one of the key players in the Escherichia coli pyridoxal 5'-phosphate (PLP) salvage pathway. This enzyme, which catalyses the reduction of pyridoxal into pyridoxine, causes pyridoxal to be converted into PLP via the formation of pyridoxine and pyridoxine phosphate. The structural and functional properties of PdxI were hitherto unknown, preventing a rational explanation of how and why this longer, detoured pathway occurs, given that, in E. coli, two pyridoxal kinases (PdxK and PdxY) exist that could convert pyridoxal directly into PLP. Here, we report a detailed characterisation of E. coli PdxI that explains this behaviour. The enzyme efficiently catalyses the reversible transformation of pyridoxal into pyridoxine, although the reduction direction is thermodynamically strongly favoured, following a compulsory-order ternary-complex mechanism. In vitro, the enzyme is also able to catalyse PLP reduction and use NADH as an electron donor, although with lower efficiency. As with all members of the aldo-keto reductase (AKR) superfamily, the enzyme has a TIM barrel fold; however, it shows some specific features, the most important of which is the presence of an Arg residue that replaces the catalytic tetrad His residue that is present in all AKRs and appears to be involved in substrate specificity. The above results, in conjunction with kinetic and static measurements of vitamins B

Indexed as

PyridoxineVitamin B 6Alcohol OxidoreductasesEscherichia coliPyridoxalPyridoxal PhosphateAlcohol OxidoreductasesPyridoxalPyridoxal PhosphatePyridoxinepyridoxine 4-dehydrogenaseVitamin B 6aldo-keto reductase superfamilykinetic mechanismPdxIvitamin B6 salvage pathwayX-ray crystallography

Identifiers

PMID37734924
PMCPMC10872706
OpenAlexW4386914375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.